Biosynex Logo

Biosynex

ISIN: FR0011005933 | Ticker: ALBIO | LEI: 969500H4BGE1HBLGP566
Sector: Health CareSub-Industry: Health Care Supplies
Country: France

About Biosynex

Company Description

Located in Strasbourg (France), the BIOSYNEX Company was born in 2005 and specialises in the design and distribution of rapid tests (RDT). Biosynex is now the French market leader in this field.

Fast and easy to use, these tests are commercialized in France and in some 90 countries through local distributors. By targeting both the public and healthcare professionals, Biosynex provides concrete effective solutions to all the latest public health issues.

Since 2020, Biosynex has been at the forefront of the Covid-19 pandemic, offering innovative screening solutions (serology tests, antigen tests, self tests and PCR).

Year founded

2005

Served area

Worldwide

Headcount

248

Headquarters

22 Boulevard Sébastien Brant, 67400 Illkirch-Graffenstaden – France

Filings & Publications

Sign up and we will give you access!

Insider Trades

Sign up and we will give you access!

Capital markets information

ISIN

FR0011005933

LEI

969500H4BGE1HBLGP566

Sector

Health Care

Industry Group

Health Care Equipment & Services

Industry

Health Care Equipment & Supplies

Sub-Industry

Health Care Supplies

Listed Stock Exchange

Euronext Paris

Main Stock Exchange

Contact Investor Relations department

Stay up to date

Keep yourself informed with the most recent updates on FinancialReports, IPOs, product advancements, and other significant news.